Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 70518-3747

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 70518-3747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Quetiapine 25mg 70518 3747 01)

Label for Quetiapine Fumarate 25 mg film-coated tablets by RemedyRepack Inc. The label indicates a quantity of 30 tablets. Includes prescription only status, NDC number 70518-3747-01, manufacturer detail (Unichem, Ghaziabad, India), storage instructions, and repackager contact information.*

FDA Label Image

Remedy_label (Remedy Label)

Quetiapine Fumarate 25 mg film-coated tablets packaging label with quantity of 30 tablets. The label shows the brand RemedyRepack and indicates the product is repackaged by RemedyRepack Inc. It includes NDC number 70518-3747-00, manufacturing source Unichem in Ghaziabad, India, and storage instructions between 20-25°C with permitted excursions. Directions advise to see package insert.*

FDA Label Image

Molecular Structure (Bc8d7cd8 989b 4839 9616 000fb74e85f0 01)

Chemical structure of quetiapine fumarate, depicting the quetiapine molecule complexed with fumaric acid in a 2:1 ratio.*

FDA Label Image

Figure 1 (Bc8d7cd8 989b 4839 9616 000fb74e85f0 02)

A line graph showing the proportion of patients with relapse (%) on the vertical axis versus time (weeks) on the horizontal axis up to 100 weeks. The graph compares two groups: QTP + LI/VAL with a dashed line and PLA + LI/VAL with a solid line, illustrating relapse rates over time for each group.*

FDA Label Image

Figure 2 (Bc8d7cd8 989b 4839 9616 000fb74e85f0 03)

A line graph depicting the proportion of patients with relapse over time in weeks. Two lines represent different patient groups labeled as QTP + LI/VAL and PLA + LI/VAL. The vertical axis shows the relapse percentage from 0 to 100%, and the horizontal axis shows time from 0 to 100 weeks. The QTP + LI/VAL group shows a higher relapse proportion compared to PLA + LI/VAL throughout the time period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.